首页> 外文会议>IEEE International Ultrasonics Symposium >Accurate diagnosis of nonalcoholic fatty liver disease in human participants via quantitative ultrasound
【24h】

Accurate diagnosis of nonalcoholic fatty liver disease in human participants via quantitative ultrasound

机译:通过定量超声准确诊断人类参与者的非酒精性脂肪肝

获取原文

摘要

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the United States, affects 30% of adult Americans, may progress to nonalcoholic steatohepatitis (NASH) and end-stage liver disease, and is a risk factor for diabetes and cardiovascular disease. The diagnosis, grading, and staging of NAFLD currently is based on liver biopsy examination with histologic assessment. Noninvasive image-based methods to evaluate the liver in adults with NAFLD are urgently needed. We developed a quantitative ultrasound (QUS) method that in animal studies shows promise for detection and quantification of liver fat content. The current study's contribution is to extend the work to human participants by assessing the accuracy of backscatter coefficient and attenuation coefficient for detection of hepatic steatosis in a cohort of adult participants with NAFLD and non-NAFLD controls. QUS parameters measured using routine clinical US scanners show promise for detecting and perhaps grading NAFLD.
机译:非酒精性脂肪肝疾病(NAFLD)是美国慢性肝病的最常见原因,影响30%的成年美国人,可能发展为非酒精性脂肪性肝炎(NASH)和终末期肝病,并且是糖尿病的危险因素和心血管疾病。目前,NAFLD的诊断,分级和分期是基于肝活检和组织学评估。迫切需要基于非侵入性图像的方法来评估成人NAFLD的肝脏。我们开发了一种定量超声(QUS)方法,该方法在动物研究中显示出检测和定量肝脂肪含量的希望。本研究的贡献在于,通过评估反向散射系数和衰减系数的准确性,以检测具有NAFLD和非NAFLD对照的成年参与者队列中的肝脂肪变性,将研究工作扩展到人类参与者。使用常规的临床US扫描仪测量的QUS参数显示出有望检测NAFLD并对其进行分级的前景。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号